Results 1 to 10 of about 447,520 (321)

Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. [PDF]

The Lancet, 2020
BACKGROUND: Preterm birth remains a common cause of neonatal mortality, with a disproportionately high burden in low-income and middle-income countries.
Achieng, Emmah, ASPIRIN Study Group, Bose, Carl L., Carlo, Waldemar A., Chicuy, Javier, Chomba, Elwyn, Das, Prabir, Derman, Richard J., Esamai, Fabian, Figueroa, Lester, Garces, Ana, Goco, Norman, Goldenberg, Robert L., Goudar, Shivaprasad S., Hemingway-Foday, Jennifer, Hibberd, Patricia L., Hoffman, Matthew K., Jessani, Saleem, Kodkany, Bhalachandra S., Koso-Thomas, Marion, Krebs, Nancy F., Kurhe, Kunal, Liechty, Edward A., Lokangaka, Adrien, McClure, Elizabeth M., Metgud, Mrityunjay, Miodovnik, Menachem, Moore, Janet, Mwapule, Abigail, Mwenechanya, Musaku, Nolen, Tracy L., Nyongesa, Paul, Okitawutshu, Jean, Patel, Archana, Saleem, Sarah, Silver, R., Somannavar, Manjunath, Tshefu, Antoinette, Zehra, Farnaz   +38 more
core   +3 more sources

'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications? [PDF]

Journal of Translational Medicine, 2008
Aspirin is one of the 'cornerstone' drugs in our current management of cardiovascular disorders. However, despite the prescription of aspirin recurrent vascular events still occur in 10–20% of patients.
Shantsila Eduard, Lip Gregory YH
doaj   +3 more sources

Investigating the role of aspirin on the mortality risk of sepsis-associated encephalopathy: a retrospective study [PDF]

Frontiers in Neurology
BackgroundSepsis-associated encephalopathy (SAE) is one of the most common complications of sepsis. Aspirin can serve as a promising therapeutic candidate and help improve patient outcomes in sepsis and its complications. However, the efficacy and safety
Fengzhen Huang, Fengzhen Huang, Fengzhen Huang, Jiping Yi, Jiping Yi, Qiuli Li, Qiuli Li, Qiuli Li, Tieqiao Zhou, Dongyou Yue, Xiaoxiang Gong, Heng Meng   +11 more
doaj   +2 more sources

Paractamol or Aspirin? [PDF]

BMJ, 1965
G. H. Jennings
openalex   +4 more sources

The prevalence and associated factors of aspirin resistance among prophylactic aspirin users [PDF]

Romanian Journal of Neurology, 2021
Background. Aspirin is an antiplatelet used for the secondary prevention after vascular events. It is also suggested for the primary prevention of vascular events in high risk people, however, despite using standard prophylactic doses, aspirin resistance
Samaneh Ghorbani-Shirkouhi, Fatemeh Ashouri, Saeideh Aghayari Sheikh Neshin, Alia Saberi, Bahador Hasanzadeh, Parisa Shahshahani   +5 more
doaj   +1 more source

Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review

Journal of Cardiovascular Development and Disease, 2023
Aspirin inhibits platelet function by irreversibly inhibiting the synthesis of thromboxane A2 (TxA2). Aspirin, at low doses, is widely used for cardiovascular prevention. Gastrointestinal discomfort, mucosal erosions/ulcerations and bleeding are frequent
Bianca Clerici, Marco Cattaneo
doaj   +1 more source

Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.

Journal of the American Medical Association (JAMA), 2022
Importance Cardiovascular disease (CVD) is the leading cause of mortality in the US, accounting for more than 1 in 4 deaths. Each year, an estimated 605 000 people in the US have a first myocardial infarction and an estimated 610 000 experience a first ...
K. Davidson, M. Barry, C. Mangione, Michael Cabana, D. Chelmow, Tumaini R. Coker, E. Davis, Katrina E. Donahue, C. Jaén, A. Krist, Martha Y. Kubik, Li Li, G. Ogedegbe, L. Pbert, J. Ruiz, J. Stevermer, Chien-Wen Tseng, J. Wong   +17 more
semanticscholar   +1 more source

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing

Research and Practice in Thrombosis and Haemostasis, 2021
Background Aspirin is important for preventing thrombotic events but also increases bleeding complications. Minimizing bleeding while preventing thrombotic events remains challenging in patients undergoing coronary artery bypass grafting (CABG ...
Laura M. Willemsen, Eline A. Vlot, Paul W. A. Janssen, Claire D. Visser, Kai Zheng, Johannes C. Kelder, Peter G. Noordzij, Erik‐Jan van den Dool, Patrick Klein, Christian M. Hackeng, Jurrien M. ten Berg   +10 more
doaj   +1 more source

Regular use of aspirin is associated with a lower cardiovascular risk in prostate cancer patients receiving gonadotropin-releasing hormone therapy

Frontiers in Oncology, 2022
Gonadotropin-releasing hormone (GnRH) therapy has been known to increase risks of major adverse cardiovascular and cerebrovascular events (MACCEs). Herein, we aim to estimate whether regular use of aspirin attenuates risks of MACCEs in prostate cancer ...
Wei-Ting Chang, Wei-Ting Chang, Wei-Ting Chang, Chon-Seng Hong, Chon-Seng Hong, Kun-Lin Hsieh, Kun-Lin Hsieh, Yi-Chen Chen, Chung−Han Ho, Chung−Han Ho, Jhih-Yuan Shih, Jhih-Yuan Shih, Wei-Chih Kan, Wei-Chih Kan, Zhih-Cherng Chen, You-Cheng Lin   +15 more
doaj   +1 more source

The dissolution of aspirin and aspirin tablets [PDF]

Journal of Pharmacy and Pharmacology, 1967
Abstract An attempt has been made to standardize the “beaker” method of measuring in vitro dissolution rates of tablets against published data for aspirin. An unexpected problem arose when it was found that samples of commercial aspirin have different intrinsic dissolution rates.
Dorothy J. Saville, A. G. Mitchell
openaire   +2 more sources